Managing Clinically Important Drug Interactions, 2/E
Facts & Comparisons(Author)
Lippincott Williams and Wilkins (Publisher)
2nd Edition
Published on 1. April 2002
Book
Paperback/Softback
647 pages
978-1-57439-138-1 (ISBN)
Article exhausted; check for reprint
Description
ow in its Second Edition, this handy book provides brief descriptions of clinically important drug interactions selected from the authoritative looseleaf reference, Drug Interactions Analysis and Management . Only level 1 and 2 interactions and those level 3 interactions most likely to affect patient outcomes are included. The information is compiled from up-to-date biomedical studies and case reports and presented in a quick-reference format. For each interaction, the authors provide a clinical significance rating and information on risk factors, similar drugs that might also interact, and patient management. The book is indexed by generic drug names, with selected trade names cross-referenced to generic equivalents.
ow in its Second Edition, this handy book provides brief descriptions of clinically important drug interactions selected from the authoritative looseleaf reference, Drug Interactions Analysis and Management . Only level 1 and 2 interactions and those level 3 interactions most likely to affect patient outcomes are included. The information is compiled from up-to-date biomedical studies and case reports and presented in a quick-reference format. For each interaction, the authors provide a clinical significance rating and information on risk factors, similar drugs that might also interact, and patient management. The book is indexed by generic drug names, with selected trade names cross-referenced to generic equivalents.
ow in its Second Edition, this handy book provides brief descriptions of clinically important drug interactions selected from the authoritative looseleaf reference, Drug Interactions Analysis and Management . Only level 1 and 2 interactions and those level 3 interactions most likely to affect patient outcomes are included. The information is compiled from up-to-date biomedical studies and case reports and presented in a quick-reference format. For each interaction, the authors provide a clinical significance rating and information on risk factors, similar drugs that might also interact, and patient management. The book is indexed by generic drug names, with selected trade names cross-referenced to generic equivalents.
More details
Edition
2nd edition
Language
English
Place of publication
Philadelphia
United States
Target group
Adult education
Dimensions
Height: 196 mm
Width: 122 mm
Weight
710 gr
ISBN-13
978-1-57439-138-1 (9781574391381)
Copyright in bibliographic data is held by Nielsen Book Services Limited or its licensors: all rights reserved.
Schweitzer Classification
Other editions
New editions
Philip D. Hansten | John R. Horn
Hansten and Horn's Managing Clinically Important Drug Interactions
Book
12/2003
4th Edition
Facts & Comparisons,U.S.
€69.60
Article is exhausted; no reprint
Previous edition
Hasten
Manage Clin Import Drug Int
Book
07/1998
Lippincott Williams and Wilkins
€96.88
Article exhausted; check for reprint